AKT1 and neoplasm: When ERβ is activated by the selective agonist KB9520, SIRT1 and FOXM1 are down regulated, resulting in increased acetylated AKT1 and interaction with PARP1, HSC70 and GADPH in tumor cells, both in vitro and in vivo.